International Cooperation

The FSBI ‘SCEEMP’ attaches particular importance to the advancement of international cooperation in order to stay informed about the activities of foreign expert and regulatory authorities, exchange best practices and methods of medicine quality, efficacy, and safety control, facilitate the development of pharmacopoeial standards, promote innovative research, education and training of highly-qualified professionals.

Cooperation with the EAEU Member States

FSBI ‘SCEEMP’ experts are involved in the work of the Pharmacopoeial Committee of the Eurasian Economic Union (EAEU), the Expert Group and the Expert Committee on Medicines under the Eurasian Economic Commission (EEC), as well as the Working Group on the Elaboration of Consistent Approaches to Medicine Regulation within the EAEU. This contributes to the prompt and effective dialogue to address the existing challenges and streamline the medicine evaluation procedures in the EAEU.

The FSBI ‘SCEEMP’ has Memoranda of Understanding and Cooperation with the expert and regulatory authorities of the EAEU Member States, it also initiated the creation of the Expert Coordination Council on Medicine Evaluation to facilitate the decision-making process and cooperation with its EAEU partners:     

  • Republican Unitary Enterprise ‘Center for Examinations and Tests in Health Service’ of the Republic of Belarus,  

  • National Center for Expertise of Medicines and Medical Devices of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan,

  • ‘Scientific Center of Drug and Medical Technology Expertise named after Academician E. Gabrielyan’ CJSC,

  • Department of Medicines and Medical Products under the Ministry of Health of the Kyrgyz Republic.

Cooperation with Foreign Partners

The FSBI ‘SCEEMP’ has a long history of cooperation with the leading international agencies:

  • European Directorate for the Quality of Medicines & Healthcare (EDQM) of the Council of Europe. The FSBI ‘SCEEMP’ has an associate member status in the General European OMCL Network (GEON), and contributes to Groups of Experts and Working Parties of the European Pharmacopoeia Commission,

  • World Health Organisation (WHO). The FSBI ‘SCEEMP’ takes part in:
    • interlaboratory studies for the establishment of WHO international standards for antibiotics (as a WHO-prequalified quality control laboratory),  
    • the interagency working group for benchmarking of the Russian regulatory system and receiving the designation as a WHO-Listed Authority (WLA),
    • meetings of the Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) and Expert Committee on Biological Standardisation (ECBS),
    • international drug monitoring programmes implemented by Uppsala Monitoring Centre (UMC)―WHO Collaborating Centre on medicine safety,

  • FSBI ‘SCEEMP’ experts contribute to the Working Groups of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). 

The FSBI ‘SCEEMP’ also maintains cooperation with:

  • National Institutes for Food and Drug Control (NIFDC), People’s Republic of China,

  • Beijing Institute for Drug Control (BIDC),

  • Russia Institute of Tsinghua University,

  • State Institution “Center for Pharmaceutical Products Safety” under the Ministry of Health of the Republic of Uzbekistan,

  • Paul-Ehrlich-Institut (PEI), a German federal agency, regulatory body and research institution for vaccines and biomedicines,

  • United States Pharmacopeia (USP),

  • Cuba’s Center for State Control of Medicines and Medical Devices (CECMED),

  • Iran Food and Drug Administration (IFDA),

  • Nicaragua Ministry of Health.